Finance

Lists
688506:SHA
Sichuan Biokin Pharmaceutical Co Ltd
233,88 CNY
+1,17%
(+2,71) 1D
16 ოქტ, 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688506...
Open
233,33 CNY
High
242,99 CNY
Low
230,10 CNY
Mkt. cap
96,56 მლრდ.
Avg. vol.
1,57 მლნ.
Volume
1,83 მლნ.
52-wk high
404,00 CNY
52-wk low
200,10 CNY
EPS
-3,79 CNY
No. of employees
3 ათ.
Open
233,33 CNY
High
242,99 CNY
Low
230,10 CNY
Mkt. cap
96,56 მლრდ.
Avg. vol.
1,57 მლნ.
Volume
1,83 მლნ.
52-wk high
404,00 CNY
52-wk low
200,10 CNY
EPS
-3,79 CNY
No. of employees
3 ათ.
News stories
From web sources and news partners
Profile
Sichuan Biokin Pharmaceutical Co., Ltd. is a publicly listed Chinese biopharmaceutical company that is headquartered in Chengdu, Sichuan. Wikipedia
About Sichuan Biokin Pharmaceutical Co Ltd
CEO-
Employees3,43 ათ.
Founded23 აგვ. 1996
Headquarters-
SectorPharmaceutical industry
Websiteen.baili-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,89 მლრდ.
454,22 მლნ.
94,59 მლნ.
92,75 მლნ.
Cost of goods sold
43,74 მლნ.
115,66 მლნ.
43,37 მლნ.
59,34 მლნ.
Cost of revenue
43,74 მლნ.
115,66 მლნ.
43,37 მლნ.
59,34 მლნ.
Research and development expenses
733,75 მლნ.
741,34 მლნ.
694,76 მლნ.
787,93 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
144,15 მლნ.
169,94 მლნ.
126,35 მლნ.
113,01 მლნ.
Operating expense
862,71 მლნ.
926,05 მლნ.
813,01 მლნ.
892,42 მლნ.
Total operating expenses
906,45 მლნ.
1,04 მლრდ.
856,38 მლნ.
951,76 მლნ.
Operating income
988,25 მლნ.
-587,49 მლნ.
-761,79 მლნ.
-859,01 მლნ.
Other non operating income
-68,11 მლნ.
68,05 მლნ.
-142,74 მლნ.
142,75 მლნ.
EBT including unusual items
942,32 მლნ.
-535,84 მლნ.
-776,15 მლნ.
-901,42 მლნ.
EBT excluding unusual items
977,50 მლნ.
-586,93 მლნ.
-841,61 მლნ.
-965,12 მლნ.
Income tax expense
318,88 მლნ.
23,26 მლნ.
-1,59 მლნ.
-38,76 მლნ.
Effective tax rate
33,84%
-4,34%
0,21%
4,30%
Other operating expenses
-15,12 მლნ.
14,55 მლნ.
-7,43 მლნ.
-9,01 მლნ.
Net income
623,44 მლნ.
-559,10 მლნ.
-774,56 მლნ.
-862,66 მლნ.
Net profit margin
32,90%
-123,09%
-818,89%
-930,11%
Earnings per share
-
-
-
-
Interest and investment income
54,03 მლნ.
56,43 მლნ.
89,48 მლნ.
36,67 მლნ.
Interest expense
-24,43 მლნ.
-26,18 მლნ.
-26,56 მლნ.
-29,06 მლნ.
Net interest expenses
29,60 მლნ.
30,26 მლნ.
62,92 მლნ.
7,62 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,01 მლრდ.
-567,21 მლნ.
-741,51 მლნ.
-836,43 მლნ.
Gain or loss from assets sale
1,06 ათ.
-1,06 ათ.
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები